Nucleus Genomics Expands Embryo Testing Product to India and Middle East

Nucleus Genomics has announced the expansion of its embryo testing product to markets in India and the Middle East. Bloomberg posted on X, highlighting the company's move to introduce its controversial product in these regions. The testing service, which has sparked debate over ethical considerations, aims to provide genetic insights for prospective parents. This expansion marks a significant step for Nucleus Genomics as it seeks to broaden its international presence and tap into new markets. The company has faced scrutiny over the implications of genetic testing, but continues to push forward with its offerings.